Study | Patients | Histological subtype (%) | FNCLCC grade (%) | Tumour status (%) | Follow-up (months) | Vascular resection (%) | Margin status (%) | 30-day mortality (%) | Complication rate (%) | RFS (%) | OS (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
Dzsinich 199216 | 13 | Lei, 100 | NA | P, 100 | 27 | IVC 100 | R0/R1 93 | 7 | 23 | 31 | 3y 38 |
Mingoli A199717 | 120 | Lei, 100 | NA | P, 100 | 32 | IVC 100 | R0/R1 100 | 3 | 6 | 42 | 5y 37 |
Hines199918 | 14 | Lei, 100 | G1, 14; G2, 29; G3, 51 | P, 100 | 25 | IVC 100 | R0/R1 86; R2 14 | 0 | NA | 43 | 5y 53 |
Hollenbeck 200319 | 21 | Lei, 100 | NA | P, 100 | 24 | IVC 100 | R0/R1 84; R2 16 | 10 | 19 | 33 | 5y 33 |
Kieffer 200620 | 20 | Lei, 100 | NA | P, 100 | 44 | IVC 100 | NA | 20 | NA | 15 | 5y 35 |
Schwarzbach 200621 | 25 | Lip, 16; Lei, 48; MFH, 8 | G1, 8; G2, 20; G3, 68 | P, 64; R, 36 | 19 | IVC 48 IV 16 AA 24 IA 12 | R0/R1 68; R2 32 | 4 | 36 | 18 | 2y 56 |
Ito 200722 | 20 | Lei, 100 | G1, 10; G2, 35; G3, 50 | P, 100 | 47 | IVC 100 | R0/R1 95; R2 5 | 0 | NA | 30 | 5y 62 |
Fiore 201223 | 15 | Lip, 7; Lei, 80 | G1, 20; G2, 27; G3, 53 | P, 100 | 32 | IVC 100 | R0/R1 100 | 0 | 7 | 67 | 3y 80 |
Mann 201224 | 17 | Lei, 100 | G1, 6; G2, 47; G3, 47 | P, 82; R, 18 | 49 | IVC 100 | R0/R1 100 | 0 | 35 | 41 | 5y 56 |
Bertrand 201625 | 22 | Lip, 54; Lei, 32 | G1, 6; G2, 42; G3, 42 | P, 65; R, 35 | 34 | IVC 59 IV 41 IA 36 AA 9 | R0/R1 100 | 0 | 18 | NA | 3y 61 |
Cananzi 201626 | 11 | Lei, 100 | G1, 27; G2, 27; G3, 36 | P, 100 | 93 | IVC 100 | R0/R1 91; R2 9 | 0 | 9 | 36 | 5y 78 |
Illuminati 201627 | 27 | Lei, 100 | NA | P, 100 | 60 | IVC 67 IV 33 | R0/R1 100 | 0 | 22 | 33 | 5y 54 |
Roland 201628 | 42 | Lei, 100 | G1, 11; G2, 26; G3, 63 | P, 100 | 60 | IVC 100 | R0/R1 80; R2 20 | 0 | NA | 35 | 5y 65 |
Tan 201629 | 67 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
Wortmann 201630 | 20 | NA | NA | P, 64; R, 36 | 24 | IV 10 IA 70 AA 25 | NA | 5 | 35 | 33 | 2y 69 |
Ikoma 201731 | 36 | Lei, 100 | NA | NA | NA | IVC 100 | R0/R1 100 | NA | NA | NA | NA |
Blair 201832 | 32 | Lip, 19; Lei, 81 | G1, 44; G2, 47; G3, 9 | P, 84; R, 16 | 37 | IVC 100 | R0/R1 91; R2 9 | 0 | 16 | 25 | 5y 50 |
Ferraris 201933 | 67 | Lip, 25; Lei, 58 | G1, 10; G2, 43; G3, 46 | P, 93; R, 7 | 58 | IVC 64 IV 42 AA 6 IA 19 | R0/R1 97; R2 3 | 3 | 22 | 40 | 5y 56 |
Homsy 202034 | 17 | Lip, 29; Lei, 59 | G1, 0; G2, 35; G3, 59 | P, 94; R, 6 | 27 | IVC 53 IV 24 AA 35 IA 18 | R0/R1 68; R2 32 | 0 | 29 | 47 | 3y 80 |
Ong 202035 | 30 | Lei, 100 | G1, 13; G2, 63; G3, 23 | P, 100 | 70 | IVC 67 IV 33 IA 20 | R0/R1 97; R2 3 | 0 | 17 | 43 | 5y 32 |
Spolverato 202110 | 24 | Lip, 100 | G1, 25; G2, 54; G3, 21 | P, 100 | 38 | IVC 38 IV 50 IA 29 | R0/R1 96; R2 4 | 0 | 54 | 52 | 5y 60 |
Goel 202236 | 24 | Lei, 100 | NA | P, 100 | 25 | IVC 100 | R0/R1 100 | 4 | 4 | 38 | 5y 25 |
Li 202237 | 15 | Lip, 53; Lei, 13 | NA | P, 60; R, 40 | 21 | IVC 20 IA 100 | R0/R1 100 | 0 | 13 | 86 | 5y 73 |